RadNet Shares Outstanding 2010-2024 | RDNT

RadNet shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • RadNet shares outstanding for the quarter ending September 30, 2024 were 0.075B, a 9.24% increase year-over-year.
  • RadNet 2023 shares outstanding were 0.065B, a 12.8% increase from 2022.
  • RadNet 2022 shares outstanding were 0.057B, a 7.3% increase from 2021.
  • RadNet 2021 shares outstanding were 0.053B, a 4.97% increase from 2020.
RadNet Annual Shares Outstanding
(Millions of Shares)
2023 65
2022 57
2021 53
2020 51
2019 50
2018 49
2017 47
2016 47
2015 45
2014 43
2013 40
2012 39
2011 39
2010 37
2009 36
RadNet Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 75
2024-06-30 73
2024-03-31 69
2023-12-31 65
2023-09-30 69
2023-06-30 61
2023-03-31 58
2022-12-31 57
2022-09-30 58
2022-06-30 57
2022-03-31 56
2021-12-31 53
2021-09-30 54
2021-06-30 53
2021-03-31 53
2020-12-31 51
2020-09-30 52
2020-06-30 51
2020-03-31 50
2019-12-31 50
2019-09-30 50
2019-06-30 50
2019-03-31 50
2018-12-31 49
2018-09-30 49
2018-06-30 49
2018-03-31 48
2017-12-31 47
2017-09-30 48
2017-06-30 47
2017-03-31 47
2016-12-31 47
2016-09-30 46
2016-06-30 47
2016-03-31 47
2015-12-31 45
2015-09-30 45
2015-06-30 45
2015-03-31 43
2014-12-31 43
2014-09-30 44
2014-06-30 43
2014-03-31 40
2013-12-31 40
2013-09-30 39
2013-06-30 40
2013-03-31 39
2012-12-31 39
2012-09-30 40
2012-06-30 39
2012-03-31 38
2011-12-31 39
2011-09-30 38
2011-06-30 40
2011-03-31 37
2010-12-31 37
2010-09-30 37
2010-06-30 37
2010-03-31 36
2009-12-31 36
2009-09-30 36
2009-06-30 36
2009-03-31 36
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $5.911B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00